Lilly negotiating with telecommunications companies; sells Hybritech monoclonals business.

LILLY PLANNING INVESTMENT IN TELEPHONALS AS IT DIVESTS 39424MONOCLONALS: behind the headlines of its recent Hybritech divestiture, the company is actively in negotiations with major telecommunication and computer firms to support its objective of building a health information network. Although the deals are not directly related, the new focus on telecommunication skills shows the change in synergies between the mid-80's and mid-90's. Lilly Chief Information Officer Tom Trainer discussed the telecommunications negotiations at a Sept. 26 meeting in London at which he described the effort as "aggressive discussions."